Nevirapine
Who holds supplier records for Nevirapine? 6 organisations hold a current record for Nevirapine: an active US FDA Type II Drug Master File or a CEP. A further 7 organisations have only historical (inactive) DMF filings. 5 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4) and China (2).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Nevirapine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/nevirapine
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
4 of the 6 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Nevirapine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 18576, 17851, 24520 +1 · latest filing Jan 2011
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 17782, 24610 · latest filing Feb 2011
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 19712, 29606 · latest filing Jul 2016
- Cipla LimitedIndia Company GMP cert on recordActive DMF 19753, 17905 · latest filing Apr 2008
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 17915 · latest filing Dec 2004
- Shanghai Desano Chemical Pharmaceutical Co., LtdChinaCEPActive DMF 21280 · latest filing Jan 2008
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (5)
Certificates of Suitability on the EDQM register for Nevirapine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District | IN | CEP 2011-075 - Rev 06 Nevirapine | Sept 2025 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2024-062 - Rev 00 Nevirapine hemihydrate | Aug 2024 | — |
| HETERO LABS LIMITED Hyderabad | IN | CEP 2016-076 - Rev 01 Nevirapine, Additional site | Jul 2024 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | R1-CEP 2016-153 - Rev 00 Nevirapine hemihydrate | Jan 2023 | — |
| SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD. Laogang Town | CN | R0-CEP 2020-267 - Rev 00 Nevirapine | Dec 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (7)
Organisations whose Type II DMFs for Nevirapine are no longer active. These show a past filing, not current supply.
Show all 7 historical records
- TYCHE INDUSTRIES LTDInactive DMF 28105 · filed Mar 2014
- MATRIX PHARMA GROUP XIAMEN LTDInactive DMF 25221 · filed Aug 2011
- MYLAN LABORATORIES LTDInactive DMF 19368, 23368 · filed Dec 2009
- India · Inactive DMF 23124 · filed Sept 2009
- India · Inactive DMF 22162 · filed Nov 2008
- RANBAXY LABORATORIES LTDInactive DMF 20088 · filed Dec 2006
- MATRIX LABORATORIES LTDInactive DMF 19379 · filed Oct 2005
Overview
Nevirapine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL57).
Chemical identity
- IUPAC name
- 2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
- Canonical SMILES
- CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
- InChIKey
- NQDJXKOVJZTUJA-UHFFFAOYSA-N
- Synonyms
- BIRG 0587, BIRG-0587, BIRG0587, Nevirapina, Nevirapine, Nevirapine anhydrous, Nevirapine, anhydrous, Nevirapine teva, Nevirapinum anhydrous, NSC-641530, Viramune, Viramune xr
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- Mechanism of action
- Cytochrome P450 2B6 Inducers; Cytochrome P450 3A Inducers; Non-Nucleoside Reverse Transcriptase Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Nevirapine?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Nevirapine: APITORIA PHARMA PRIVATE LTD (India), Hetero Labs Limited (India), Zhejiang Huahai Pharmaceutical Co., Ltd. (China), Cipla Limited (India), MATRIX PHARMACORP PRIVATE LTD (India) and Shanghai Desano Chemical Pharmaceutical Co., Ltd (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Nevirapine Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 18576, 17851), Hetero Labs Limited (DMF 17782, 24610), Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 19712, 29606), Cipla Limited (DMF 19753, 17905), MATRIX PHARMACORP PRIVATE LTD (DMF 17915) and Shanghai Desano Chemical Pharmaceutical Co., Ltd (DMF 21280). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Nevirapine records mean?
7 organisations have only inactive Type II DMFs for Nevirapine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Nevirapine have a European Certificate of Suitability?
Yes. 5 organisations hold a valid CEP for Nevirapine on the EDQM register, including MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), HETERO LABS LIMITED Hyderabad (IN), ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai (CN) and SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD. Laogang Town (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Nevirapine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Nevirapine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.